|Bid||37.79 x 2200|
|Ask||37.85 x 2200|
|Day's Range||37.67 - 38.58|
|52 Week Range||27.88 - 40.97|
|Beta (5Y Monthly)||0.73|
|PE Ratio (TTM)||14.96|
|Earnings Date||Oct 27, 2020 - Nov 02, 2020|
|Forward Dividend & Yield||1.52 (3.96%)|
|Ex-Dividend Date||Jul 30, 2020|
|1y Target Est||41.85|
Both Inovio and BionNTech announced that they are making headway in their coronavirus vaccine trials, and will be able to meet deadlines toward the end of the year or a the start of 2021. Yahoo Finance’s Anjalee Khemlani breaks down the latest news about the coronavirus on The Final Round.
Latest news and updates and the global coronavirus pandemic.
COMPANY CLOSE UPDATES Terrence Horan Shares of Johnson & Johnson JNJ slumped 0.72% to $146.97 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.